BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12883390)

  • 1. Trends in testicular cancer incidence in Vaud, Switzerland.
    Levi F; Te VC; Randimbison L; La Vecchia C
    Eur J Cancer Prev; 2003 Aug; 12(4):347-9. PubMed ID: 12883390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testicular cancer incidence in eight northern European countries: secular and recent trends.
    Richiardi L; Bellocco R; Adami HO; Torrång A; Barlow L; Hakulinen T; Rahu M; Stengrevics A; Storm H; Tretli S; Kurtinaitis J; Tyczynski JE; Akre O
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2157-66. PubMed ID: 15598775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in testicular germ cell cancer incidence in Australia.
    Baade P; Carrière P; Fritschi L
    Cancer Causes Control; 2008 Dec; 19(10):1043-9. PubMed ID: 18478339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The epidemiology of tumors of the testes in the Netherlands: accurate rendering by the Registry of Histopathology and Cytopathology (PALGA)].
    Post PN; Casparie MK; ten Kate FJ; Oosterhuis JW
    Ned Tijdschr Geneeskd; 2004 Jun; 148(23):1150-4. PubMed ID: 15211966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996.
    Weir HK; Marrett LD; Moravan V
    CMAJ; 1999 Jan; 160(2):201-5. PubMed ID: 9951441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The increasing burden of testicular seminomas and non-seminomas in adolescents and young adults (AYAs): incidence, treatment, disease-specific survival and mortality trends in the Netherlands between 1989 and 2019.
    van der Meer DJ; Karim-Kos HE; Elzevier HW; Dinkelman-Smit M; Kerst JM; Atema V; Lehmann V; Husson O; van der Graaf WTA
    ESMO Open; 2024 Feb; 9(2):102231. PubMed ID: 38244349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clues to the aetiological heterogeneity of testicular seminomas and non-seminomas: time trends and age-period-cohort effects.
    Liu S; Semenciw R; Waters C; Wen SW; Mery LS; Mao Y
    Int J Epidemiol; 2000 Oct; 29(5):826-31. PubMed ID: 11034964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries.
    Bray F; Richiardi L; Ekbom A; Forman D; Pukkala E; Cuninkova M; Møller H
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):652-8. PubMed ID: 16614105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007.
    Trabert B; Chen J; Devesa SS; Bray F; McGlynn KA
    Andrology; 2015 Jan; 3(1):4-12. PubMed ID: 25331326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtype-specific incidence of testicular cancer in Germany: a pooled analysis of nine population-based cancer registries.
    Stang A; Rusner C; Eisinger B; Stegmaier C; Kaatsch P
    Int J Androl; 2009 Aug; 32(4):306-16. PubMed ID: 18179558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark.
    Jacobsen R; Møller H; Thoresen SØ; Pukkala E; Kjaer SK; Johansen C
    Int J Androl; 2006 Feb; 29(1):199-204. PubMed ID: 16371112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population based incidence and age distribution of spermatocytic seminoma.
    Carrière P; Baade P; Fritschi L
    J Urol; 2007 Jul; 178(1):125-8. PubMed ID: 17499277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Age and Histology of Testicular Cancer from 1980-2019: A Single-Center Study.
    Yamashita S; Koyama J; Goto T; Fujii S; Yamada S; Kawasaki Y; Kawamorita N; Mitsuzuka K; Arai Y; Ito A
    Tohoku J Exp Med; 2020 Nov; 252(3):219-224. PubMed ID: 33148936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular cancer trends in the Canton of Vaud, Switzerland, 1974-1987.
    Levi F; Te VC; La Vecchia C
    Br J Cancer; 1990 Nov; 62(5):871-3. PubMed ID: 2245183
    [No Abstract]   [Full Text] [Related]  

  • 15. Testicular cancer among US men aged 50 years and older.
    Ghazarian AA; Rusner C; Trabert B; Braunlin M; McGlynn KA; Stang A
    Cancer Epidemiol; 2018 Aug; 55():68-72. PubMed ID: 29807233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of testicular germ-cell malignancies in England and Wales: trends in children compared with adults.
    dos Santos Silva I; Swerdlow AJ; Stiller CA; Reid A
    Int J Cancer; 1999 Nov; 83(5):630-4. PubMed ID: 10521799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania.
    Drevinskaite M; Patasius A; Kincius M; Jievaltas M; Smailyte G
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480363
    [No Abstract]   [Full Text] [Related]  

  • 18. Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.
    Lerro CC; Robbins AS; Fedewa SA; Ward EM
    Urol Oncol; 2014 Jan; 32(1):23.e15-21. PubMed ID: 23395701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in testicular carcinoma in England and Wales, 1971-99.
    Power DA; Brown RS; Brock CS; Payne HA; Majeed A; Babb P
    BJU Int; 2001 Mar; 87(4):361-5. PubMed ID: 11251531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time trends and occupational variation in the incidence of testicular cancer in the Nordic countries.
    Ylönen O; Jyrkkiö S; Pukkala E; Syvänen K; Boström PJ
    BJU Int; 2018 Sep; 122(3):384-393. PubMed ID: 29460991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.